![]() |
市場調査レポート
商品コード
1520538
動物用ヘルスケア市場レポート:製品タイプ、動物タイプ、エンドユーザー、地域別、2024年~2032年Veterinary Healthcare Market Report by Product, Animal Type, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
動物用ヘルスケア市場レポート:製品タイプ、動物タイプ、エンドユーザー、地域別、2024年~2032年 |
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2~3営業日
|
世界の動物用ヘルスケアの市場規模は2023年に433億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに806億米ドルに達し、2024年から2032年の間に7%の成長率(CAGR)を示すと予測しています。様々な人獣共通感染症、食品媒介感染症、慢性疾患の有病率の増加、動物の健康に対する飼い主の関心の高まり、獣医健康情報システムの導入は、市場を推進している主な要因の一部です。
市場の成長と規模動物用ヘルスケア分野は、ペット飼育の増加動向と動物の健康に対する意識の高まりから、現在大幅な成長段階にあります。この分野の拡大は、獣医学的診断と治療介入における革新的な進歩によって大きく推進され、投資と起業家ベンチャーにとって魅力的な道として確立されています。
主な市場促進要因:人獣共通感染症の増加により、包括的な動物ヘルスケア・サービスの必要性が高まっています。さらに、ペット保険業界の拡大とペットケアへの支出の急増は、動物福祉に対する社会の価値観の進化を裏付けています。
主要市場動向:この市場の新たな動向は、遠隔医療とモバイル技術の統合によって特徴付けられ、遠隔診察機能と継続的な健康モニタリングを通じて、獣医療へのアクセスと効率を再定義しています。この業界はまた、個別化されたペット栄養と先制的ヘルスケア・ソリューションに徐々に軸足を移しつつあり、より個別化された包括的な動物医療戦略への包括的なシフトを反映しています。
地理的動向:地域情勢別では、市場の競合情勢は激しく、主要企業は戦略的合併、買収、提携に重点を置き、事業範囲を拡大し、提供する製品のポートフォリオを充実させています。医薬品やワクチンの革新と診断技術の進歩は、これらの企業が競争力を確保し、動物医療のダイナミックな要求に適応するために採用する重要な戦略です。
競合情勢:競合環境は、研究開発への多額の投資、戦略的パートナーシップ、新市場への参入など、製品アレイの増強と市場支配力の強化を目的とした有力企業の戦略的イニシアティブによって規定されます。
課題と機会:とはいえ、この分野は、獣医サービスに関連する法外なコストや、世界の動物衛生規制の不統一といった課題に直面しており、市場の成長を制限する可能性があります。逆に、動物の疾病の蔓延の高まりや、急成長する経済圏における未開拓の市場は、この分野の拡大と革新的な動物用ヘルスケアソリューションの出現に大きな展望を与えています。
さまざまな人獣共通感染症、食品媒介感染症、慢性疾患の流行増加
人獣共通感染症(動物から人へ感染する病気)が世界の健康問題であり続ける中、ペットの飼い主や畜産農家が獣医療サービスを求める傾向が強まっています。この需要の急増には、定期検診、ワクチン接種、動物の病気の診断と治療が含まれ、これは動物自身の健康のためであると同時に、人間への病気感染のリスクを軽減するためでもあります。さらに、ペットのがんなどの慢性疾患の罹患率が上昇していることも、高度な診断と治療に対する需要を煽っています。動物用ヘルスケア・プロバイダーは、これらの病気を効果的に診断・管理するために、高度な医療技術や医薬品を使用するようになってきています。これが動物用診断薬・治療薬市場の成長を後押ししています。
動物の健康に対する飼い主の関心の高まり
動物の健康に関心が高い飼い主は、予防的な獣医療を求める傾向が強いです。これには、定期検診、ワクチン接種、歯科治療、寄生虫駆除などが含まれます。予防措置の重要性に対する意識の高まりは、獣医療サービスの利用率の上昇につながり、業界の収益を押し上げています。さらに、心配性のペットの飼い主は、ペットの特定の健康問題に対処するために、心臓病学、皮膚病学、腫瘍学などの専門的な獣医サービスを求めることがあります。この動向は獣医の専門分野の拡大につながり、市場に新たな収益源を生み出しています。そのほか、動物の健康に対する関心の高まりも、ペット保険の導入増加につながっています。ペットの飼い主は、獣医療費をカバーする保険に投資する傾向が強いです。これにより経済的な安全が確保され、ペットの飼い主は必要なヘルスケアをためらうことなく受けることができるようになり、動物用ヘルスケア市場をさらに後押ししています。
動物医療情報システムのイントロダクション
VHISにより、獣医師は個々の動物の包括的で最新の医療記録に素早くアクセスできるようになります。これは、より良い情報に基づいた診断と治療計画を意味します。動物の健康に関する完全な履歴をすぐに利用できることで、獣医師はより正確な判断を下すことができ、患者の転帰の改善につながります。さらに、VHISはリアルタイムでの健康データの収集と分析を可能にします。この機能は、病気の発生やパターンを追跡するのに特に価値があります。健康問題を早期に特定し、疾病動向を監視することで、獣医師と公衆衛生当局は、動物と人間の両方に影響を及ぼす人獣共通感染症を含む新たな脅威に対して、より効果的に対応することができます。その上、VHISは獣医専門家間のコミュニケーションと協力を促進します。患者のデータ、画像、検査結果を安全に共有できるため、専門医に相談したり、セカンド・オピニオンを求めたりする際に非常に有用です。このような専門家間の相互接続は、動物のより包括的で効果的なケアにつながり、市場を促進します。
The global veterinary healthcare market size reached US$ 43.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 80.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032. The increasing prevalence of various zoonotic, food-borne, and chronic diseases, the rising concerns of pet owners toward animal health, and the introduction of veterinary health information systems are some of the major factors propelling the market.
Market Growth and Size: The domain of veterinary healthcare is currently undergoing a substantial phase of growth, attributed to the increasing trend of pet ownership and a heightened collective consciousness regarding animal health. This sector's expansion is significantly propelled by innovative strides in veterinary diagnostics and therapeutic interventions, establishing it as an appealing avenue for investment and entrepreneurial ventures.
Major Market Drivers: Central to the market's momentum are the escalating incidences of zoonotic diseases, which amplify the necessity for comprehensive animal healthcare services. Moreover, the expansion of the pet insurance industry alongside a surge in expenditures on pet care underscores an evolving societal valorization of animal welfare.
Key Market Trends: Emerging trends within this market are notably characterized by the integration of telemedicine and mobile technologies, which are redefining the accessibility and efficiency of veterinary care through remote consultation capabilities and continuous health monitoring. The industry is also witnessing a gradual pivot towards individualized pet nutrition and preemptive healthcare solutions, reflecting an overarching shift towards more tailored and all-encompassing animal health care strategies.
Geographical Trends: Geographically, the landscape of the market is intensely competitive, with key entities focusing on strategic mergers, acquisitions, and collaborations to broaden their operational scope and enrich their portfolio of offerings. Innovations in pharmaceuticals and vaccines, coupled with advancements in diagnostic technologies, are crucial strategies employed by these corporations to secure a competitive stance and adapt to the dynamic requisites of animal healthcare.
Competitive Landscape: The competitive milieu is delineated by the strategic initiatives of prominent firms, including substantial investments in research and development, strategic partnerships, and ventures into new markets, all aimed at augmenting their product arrays and fortifying their market dominance.
Challenges and Opportunities: Notwithstanding, the sector is confronted with challenges such as the prohibitive costs associated with veterinary services and the inconsistency in global animal health regulations, which could potentially restrict market growth. Conversely, the escalating prevalence of animal ailments and the unexplored markets in burgeoning economies present significant prospects for the sector's enlargement and the advent of innovative veterinary healthcare solutions.
Increasing prevalence of various zoonotic, food-borne, and chronic diseases
As zoonotic diseases (those that can be transmitted from animals to humans) continue to be a global health concern, pet owners and livestock farmers are increasingly seeking veterinary services. This surge in demand includes routine check-ups, vaccinations, and the diagnosis and treatment of illnesses in animals, both for the health of the animals themselves and to mitigate the risk of disease transmission to humans. Moreover, the rising incidence of chronic diseases, such as cancer in pets, has fueled the demand for advanced diagnostics and therapeutic treatments. Veterinary healthcare providers are increasingly using advanced medical technologies and pharmaceuticals to diagnose and manage these diseases effectively. This, in turn, drives growth in the market for veterinary diagnostics and therapeutics.
Rising concerns of pet owners toward animal health
Pet owners who are more concerned about their animals' health are more likely to seek preventive veterinary care. This includes regular check-ups, vaccinations, dental care, and parasite control. The heightened awareness of the importance of preventive measures has led to a rise in the utilization of veterinary services, driving revenue in the industry. Moreover, concerned pet owners may seek out specialized veterinary services such as cardiology, dermatology, and oncology to address specific health issues in their pets. This trend has led to the expansion of veterinary specialties, creating additional revenue streams within the market. Besides, the rising concern for animal health has also led to an increase in the adoption of pet insurance. Pet owners are more likely to invest in insurance policies that cover veterinary expenses. This provides financial security and allows pet owners to pursue necessary healthcare without hesitation, further boosting the veterinary healthcare market.
Introduction of veterinary health information systems
VHIS enables veterinarians to access comprehensive and up-to-date medical records for individual animals quickly. This means better-informed diagnoses and treatment plans. By having a complete history of an animal's health readily available, veterinarians can make more accurate decisions, leading to improved patient outcomes. Moreover, VHIS allows for the collection and analysis of health data in real-time. This capability is especially valuable for tracking disease outbreaks and patterns. By identifying health issues early and monitoring disease trends, veterinarians and public health officials can respond more effectively to emerging threats, including zoonotic diseases that can affect both animals and humans. Besides, VHIS facilitates communication and collaboration among veterinary professionals. It enables sharing of patient data, images, and test results securely, which can be invaluable for consulting with specialists or seeking second opinions. This interconnectedness among professionals can lead to more comprehensive and effective care for animals, thus propelling the market.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, animal type, and end user.
Therapeutics
Vaccines
Parasiticides
Anti-Infectives
Medical Feed Additives
Others
Diagnostics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Others
Therapeutics represent the most used products
The report has provided a detailed breakup and analysis of the market based on the product. This includes therapeutics (vaccines, parasiticides, anti-infectives, medical feed additives, and others) and diagnostics (immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, and others). According to the report, therapeutics represented the largest segment.
Therapeutics are primarily used to treat various health conditions in animals. This includes medications and treatments for infectious diseases, chronic illnesses, injuries, and other medical issues. Veterinary therapeutics are essential for alleviating suffering and improving the quality of life for animals in need of medical care. Moreover, therapeutics also encompass preventive treatments such as vaccines and parasite control products. These are administered to animals to prevent diseases and health problems from occurring in the first place. Preventive therapeutics play a crucial role in maintaining the overall health of animals and reducing the spread of diseases. Besides, certain health issues in animals are quite common and require ongoing treatment. For instance, conditions like arthritis, allergies, and dental problems are frequently encountered in pets. Therapeutic products provide ongoing relief and management for these common ailments.
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Others
A detailed breakup and analysis of the market based on the animal type has also been provided in the report. This includes dogs and cats, horses, ruminants, swine, poultry, and others.
Dogs and cats category includes veterinary healthcare services, treatments, and products specifically designed for dogs and cats, which are among the most common domestic pets. It encompasses routine check-ups, vaccinations, surgeries, medications, and preventive care for these beloved companion animals.
Ruminants are a group of mammals that includes animals like cattle, sheep, and goats. Veterinary healthcare for ruminants involves herd health management, reproductive services, nutrition assessment, and treatment of diseases and conditions affecting these animals, which are often raised for meat, milk, and wool.
Swine veterinary healthcare is directed at the health and well-being of pigs, which are primarily raised for pork production. Services in this category include disease prevention, vaccination programs, nutrition analysis, and treatment of swine-specific health issues.
Poultry healthcare focuses on the health and management of birds raised for meat and egg production. This category includes services like disease control, vaccination, nutritional guidance, and addressing various poultry-related health concerns to ensure the quality and safety of poultry products.
Veterinary Hospitals
Veterinary Clinics
Veterinary Laboratory Testing Services
Others
Veterinary hospitals accounts for the majority of market share
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes veterinary hospitals, veterinary clinics, veterinary laboratory testing services, and others. According to the report, veterinary hospitals accounted for the largest market share.
Veterinary hospitals are equipped to provide a wide range of services under one roof. This includes routine check-ups, surgeries, diagnostic imaging, laboratory testing, dental care, and emergency services. The ability to offer comprehensive care makes veterinary hospitals a one-stop solution for pet owners, which is convenient and reassuring. Moreover, many veterinary hospitals have specialists on staff, such as surgeons, dermatologists, and cardiologists. This enables them to handle complex cases and offer specialized treatments that may not be available in smaller clinics. Pet owners are often willing to seek out veterinary hospitals for access to these specialized services.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America has one of the highest rates of pet ownership in the world. Dogs, cats, and other companion animals are integral parts of many households in the region. This large pet population drives the demand for veterinary services and healthcare products. The veterinary healthcare infrastructure in North America is highly developed. It boasts a vast network of veterinary hospitals, clinics, and specialized centers equipped with state-of-the-art medical technology and highly trained professionals. This advanced infrastructure attracts pet owners seeking the best care for their animals. Besides, pet owners in North America tend to prioritize the wellness and health of their animals. This includes preventive care, routine check-ups, vaccinations, and nutritional guidance. The emphasis on proactive healthcare contributes to a steady demand for veterinary services.
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are investing in research and development to create innovative veterinary healthcare products. This includes the development of new pharmaceuticals, vaccines, diagnostic tools, and medical devices that offer improved efficacy, safety, and convenience for both veterinarians and pet owners. They are also forming strategic alliances and collaborations with other organizations, including veterinary hospitals, research institutions, and pharmaceutical manufacturers for the development of new products, joint research projects, and expanded distribution networks. Besides, some companies are investing in training and educational programs for veterinarians and veterinary technicians to build relationships with the veterinary community and ensure that professionals are well-versed in using their products and technologies.
Animalcare Group plc
Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
Ceva Animal Health LLC
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
Heska Corporation
IDEXX Laboratories Inc.
INDICAL Bioscience GmbH (Vimian Group)
Merck & Co. Inc.
Norbrook Laboratories Ltd
Vetoquinol India Animal Health Pvt Ltd (Vetoquinol S.A.)
Virbac
Zoetis Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Zoetis Inc. recently announced the acquisition of Abaxis, a global leader in veterinary diagnostics, to expand their product portfolio and strengthen their position in the market.
Boehringer Ingelheim International GmbH has been investing in research and development to develop advanced solutions for animal health. They have recently introduced a novel product for the treatment of respiratory diseases in pigs, which is expected to enhance their market presence.
Elanco Animal Health Incorporated has recently partnered with a biotechnology company to develop innovative solutions for animal health, aiming to provide better healthcare options for animals.